NAD⁺ augmentation in brain aging: a forum on evidence, challenges and research priorities
A forum states that restoring NAD to physiological levels shows promise against brain aging and neurodegeneration, supported by preclinical and growing clinical evidence, while measurement validity, brain delivery, optimal dosing and trial design remain key challenges. [1]
Automatic summary · not editorially reviewed
The key findings
The forum says restoring NAD to physiological levels shows promise for countering brain aging and neurodegeneration, backed by preclinical and growing clinical evidence. [1]
Key challenges named are measurement validity, brain delivery, optimal dosing and trial design. [1]
The forum examines current evidence, addresses controversies and outlines priorities for future research and translation. [1]
The source at a glance
- Study type / format
- Forum article abstract
- Population / context
- Brain aging and neurodegeneration research, as discussed in a forum article
- Summary based on
- Study abstract
- Original publication
- September 22, 2026
Forum on NAD⁺ and brain aging evidence
This forum article examines restoring NAD to physiological levels as an approach to countering brain aging and neurodegeneration. The abstract says this shows promise, backed by preclinical and growing clinical evidence. It does not report specific studies, participants, outcomes or effect sizes.
Supporting source [1]
Named challenges: measurement, delivery, dosing, trials
The abstract lists key remaining challenges: measurement validity, brain delivery, optimal dosing and trial design. It says the forum addresses ongoing controversies and outlines priorities for future research and translation. These are stated as open issues, not resolved findings.
Supporting source [1]
Abstract-only scope of this forum summary
The supplied text is only the abstract of a forum article. It gives no study design, sample size, follow-up, measured outcomes or numerical results, so the promise described cannot be weighed here. The full text was not reviewed.
Supporting source [1]
How to interpret this
Only the abstract was supplied; the full text was not reviewed. No study design, sample, follow-up, outcomes or numbers are reported, and the described promise is not quantified.
Based on the study abstract; the full paper, tables and supplementary data were not reviewed.
Source & supporting passages
Wang HL, Zhang J, Fang EF. · europepmc.org · September 22, 2026